Key facts
- This page summarizes Anthony Vuoto's Form 4 filing for IRADIMED CORP (IRMD).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 13 Dec 2024, 16:00.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
Restricted stock units convert into common stock on a one-for-one basis.
Footnote F2
On December 11, 2024, the reporting person received restricted stock units under Iradimed Corporation's 2023 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 11, 2025 Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.